Our goal is to develop innovative solutions to current problems faced by patients and healthcare providers when they use or prescribe medicine. These problems may be high cost, inconvenient dosage forms, or unsafe formulations. We are currently developing an exciting pipeline of generic and 505(b)(2) oral and injectable pharmaceutical products. Contact us today for partnership or licensing opportunities.
Meet with us at: DCAT, March 18 - 21, New York Interphex, April 2 - 4, New York CPHI North America, April 30 - May 2, Chicago Call 314-974-7385 or email email@example.com to set-up a meeting